MSD has commenced the Phase III trial to assess zilovertamab vedotin combined with R-CHP to treat individuals with previously ...

MSD said that its sotatercept steering committee called for the trial to end as patients are moved to the ongoing open-label ...

MSD has started a phase 3 trial of ROR1-directed zilovertamab vedotin (zilo-V) as a treatment for previously untreated ...

Drugmaker pauses HPV Gardasil exports as rival Pfizer gets boost from better than expected Covid vaccine and pill sales ...

"Our company's continued ambition to expand MSD's Irish footprint is a testament to the unique ecosystem around us, and in particular speaks to the passion, commitment, and talent of our existing ...

Levi Strauss trades at a high P/E of 15x, which is not justified given its modest growth rate and reliance on a favorable ...

The US Food and Drug Administration (FDA) will soon decide on whether to expand the label of MSD’s Welireg (belzutifan) to include its use for the treatment of the rare cancer pheochromocytoma and ...

MSD and Eisai’s trial saw mixed success with its two primary endpoints, seeing success in progression-free survival, but missing out on overall survival.

Dubai, UAE: MSD, a leading biopharmaceutical company, has established a new office in Dubai, further solidifying its ...

MSD Hungary, the local affiliate of the global innovative pharmaceutical company MSD, announced the appointment of Sean R.